0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
In-vitro Diagnostics Enzymes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-11D5939
Home | Market Reports | Health| Nursing
Global In vitro Diagnostics Enzymes Market Size Status and Forecast 2021 2027
BUY CHAPTERS

In-vitro Diagnostics Enzymes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11D5939
Report
October 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In-vitro Diagnostics Enzymes - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

In-vitro Diagnostics Enzymes - Market

In-vitro Diagnostics Enzymes - Market

Enzyme analysis, in blood serum, measurement of the activity of specific enzymes in a sample of blood serum, usually for the purpose of identifying a disease. The enzymes that are used for the detection/diagnosis or prognosis of disease conditions are called “diagnostic enzymes.
The global market for In-vitro Diagnostics Enzymes was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostics Enzymes, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In-vitro Diagnostics Enzymes by region & country, by Type, and by Application.
The In-vitro Diagnostics Enzymes market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostics Enzymes.
Market Segmentation

Scope of In-vitro Diagnostics Enzymes - Market Report

Report Metric Details
Report Name In-vitro Diagnostics Enzymes - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, Codexis, Inc., F. Hoffmann-La Roche Ltd., Amano Enzyme Inc., Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, Affymetrix, American Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of In-vitro Diagnostics Enzymes manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of In-vitro Diagnostics Enzymes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of In-vitro Diagnostics Enzymes in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the In-vitro Diagnostics Enzymes - Market report?

Ans: The main players in the In-vitro Diagnostics Enzymes - Market are Merck KGaA, Codexis, Inc., F. Hoffmann-La Roche Ltd., Amano Enzyme Inc., Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Amicogen, Dyadic International, BBI Solutions, Affymetrix, American Laboratories

What are the Application segmentation covered in the In-vitro Diagnostics Enzymes - Market report?

Ans: The Applications covered in the In-vitro Diagnostics Enzymes - Market report are Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs

What are the Type segmentation covered in the In-vitro Diagnostics Enzymes - Market report?

Ans: The Types covered in the In-vitro Diagnostics Enzymes - Market report are Proteases, Polymerase & Transcriptase, Ribonuclease, Others

Recommended Reports

In-Vitro Diagnostics

Diagnostic Testing

Laboratory Services

1 Market Overview
1.1 In-vitro Diagnostics Enzymes Product Introduction
1.2 Global In-vitro Diagnostics Enzymes Market Size Forecast
1.3 In-vitro Diagnostics Enzymes Market Trends & Drivers
1.3.1 In-vitro Diagnostics Enzymes Industry Trends
1.3.2 In-vitro Diagnostics Enzymes Market Drivers & Opportunity
1.3.3 In-vitro Diagnostics Enzymes Market Challenges
1.3.4 In-vitro Diagnostics Enzymes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global In-vitro Diagnostics Enzymes Players Revenue Ranking (2023)
2.2 Global In-vitro Diagnostics Enzymes Revenue by Company (2019-2024)
2.3 Key Companies In-vitro Diagnostics Enzymes Manufacturing Base Distribution and Headquarters
2.4 Key Companies In-vitro Diagnostics Enzymes Product Offered
2.5 Key Companies Time to Begin Mass Production of In-vitro Diagnostics Enzymes
2.6 In-vitro Diagnostics Enzymes Market Competitive Analysis
2.6.1 In-vitro Diagnostics Enzymes Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by In-vitro Diagnostics Enzymes Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostics Enzymes as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Proteases
3.1.2 Polymerase & Transcriptase
3.1.3 Ribonuclease
3.1.4 Others
3.2 Global In-vitro Diagnostics Enzymes Sales Value by Type
3.2.1 Global In-vitro Diagnostics Enzymes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global In-vitro Diagnostics Enzymes Sales Value, by Type (2019-2030)
3.2.3 Global In-vitro Diagnostics Enzymes Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma & Biotech
4.1.2 Hospital & Diagnostic Labs
4.1.3 Contract Research Organizations (CROs)
4.1.4 Academic Labs
4.2 Global In-vitro Diagnostics Enzymes Sales Value by Application
4.2.1 Global In-vitro Diagnostics Enzymes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global In-vitro Diagnostics Enzymes Sales Value, by Application (2019-2030)
4.2.3 Global In-vitro Diagnostics Enzymes Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global In-vitro Diagnostics Enzymes Sales Value by Region
5.1.1 Global In-vitro Diagnostics Enzymes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global In-vitro Diagnostics Enzymes Sales Value by Region (2019-2024)
5.1.3 Global In-vitro Diagnostics Enzymes Sales Value by Region (2025-2030)
5.1.4 Global In-vitro Diagnostics Enzymes Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America In-vitro Diagnostics Enzymes Sales Value, 2019-2030
5.2.2 North America In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe In-vitro Diagnostics Enzymes Sales Value, 2019-2030
5.3.2 Europe In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific In-vitro Diagnostics Enzymes Sales Value, 2019-2030
5.4.2 Asia Pacific In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America In-vitro Diagnostics Enzymes Sales Value, 2019-2030
5.5.2 South America In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa In-vitro Diagnostics Enzymes Sales Value, 2019-2030
5.6.2 Middle East & Africa In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value
6.3 United States
6.3.1 United States In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.3.2 United States In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.4.2 Europe In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.5.2 China In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.5.3 China In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.6.2 Japan In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.7.2 South Korea In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.8.2 Southeast Asia In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India In-vitro Diagnostics Enzymes Sales Value, 2019-2030
6.9.2 India In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
6.9.3 India In-vitro Diagnostics Enzymes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Profile
7.1.2 Merck KGaA Main Business
7.1.3 Merck KGaA In-vitro Diagnostics Enzymes Products, Services and Solutions
7.1.4 Merck KGaA In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.1.5 Merck KGaA Recent Developments
7.2 Codexis, Inc.
7.2.1 Codexis, Inc. Profile
7.2.2 Codexis, Inc. Main Business
7.2.3 Codexis, Inc. In-vitro Diagnostics Enzymes Products, Services and Solutions
7.2.4 Codexis, Inc. In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.2.5 Codexis, Inc. Recent Developments
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Profile
7.3.2 F. Hoffmann-La Roche Ltd. Main Business
7.3.3 F. Hoffmann-La Roche Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
7.3.4 F. Hoffmann-La Roche Ltd. In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.3.5 Amano Enzyme Inc. Recent Developments
7.4 Amano Enzyme Inc.
7.4.1 Amano Enzyme Inc. Profile
7.4.2 Amano Enzyme Inc. Main Business
7.4.3 Amano Enzyme Inc. In-vitro Diagnostics Enzymes Products, Services and Solutions
7.4.4 Amano Enzyme Inc. In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.4.5 Amano Enzyme Inc. Recent Developments
7.5 Advanced Enzymes Technologies Ltd.
7.5.1 Advanced Enzymes Technologies Ltd. Profile
7.5.2 Advanced Enzymes Technologies Ltd. Main Business
7.5.3 Advanced Enzymes Technologies Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
7.5.4 Advanced Enzymes Technologies Ltd. In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.5.5 Advanced Enzymes Technologies Ltd. Recent Developments
7.6 Biocatalysts Ltd.
7.6.1 Biocatalysts Ltd. Profile
7.6.2 Biocatalysts Ltd. Main Business
7.6.3 Biocatalysts Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
7.6.4 Biocatalysts Ltd. In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.6.5 Biocatalysts Ltd. Recent Developments
7.7 Amicogen
7.7.1 Amicogen Profile
7.7.2 Amicogen Main Business
7.7.3 Amicogen In-vitro Diagnostics Enzymes Products, Services and Solutions
7.7.4 Amicogen In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.7.5 Amicogen Recent Developments
7.8 Dyadic International
7.8.1 Dyadic International Profile
7.8.2 Dyadic International Main Business
7.8.3 Dyadic International In-vitro Diagnostics Enzymes Products, Services and Solutions
7.8.4 Dyadic International In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.8.5 Dyadic International Recent Developments
7.9 BBI Solutions
7.9.1 BBI Solutions Profile
7.9.2 BBI Solutions Main Business
7.9.3 BBI Solutions In-vitro Diagnostics Enzymes Products, Services and Solutions
7.9.4 BBI Solutions In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.9.5 BBI Solutions Recent Developments
7.10 Affymetrix
7.10.1 Affymetrix Profile
7.10.2 Affymetrix Main Business
7.10.3 Affymetrix In-vitro Diagnostics Enzymes Products, Services and Solutions
7.10.4 Affymetrix In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.10.5 Affymetrix Recent Developments
7.11 American Laboratories
7.11.1 American Laboratories Profile
7.11.2 American Laboratories Main Business
7.11.3 American Laboratories In-vitro Diagnostics Enzymes Products, Services and Solutions
7.11.4 American Laboratories In-vitro Diagnostics Enzymes Revenue (US$ Million) & (2019-2024)
7.11.5 American Laboratories Recent Developments
8 Industry Chain Analysis
8.1 In-vitro Diagnostics Enzymes Industrial Chain
8.2 In-vitro Diagnostics Enzymes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 In-vitro Diagnostics Enzymes Sales Model
8.5.2 Sales Channel
8.5.3 In-vitro Diagnostics Enzymes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. In-vitro Diagnostics Enzymes Market Trends
    Table 2. In-vitro Diagnostics Enzymes Market Drivers & Opportunity
    Table 3. In-vitro Diagnostics Enzymes Market Challenges
    Table 4. In-vitro Diagnostics Enzymes Market Restraints
    Table 5. Global In-vitro Diagnostics Enzymes Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global In-vitro Diagnostics Enzymes Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies In-vitro Diagnostics Enzymes Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies In-vitro Diagnostics Enzymes Product Type
    Table 9. Key Companies Time to Begin Mass Production of In-vitro Diagnostics Enzymes
    Table 10. Global In-vitro Diagnostics Enzymes Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostics Enzymes as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global In-vitro Diagnostics Enzymes Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global In-vitro Diagnostics Enzymes Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global In-vitro Diagnostics Enzymes Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global In-vitro Diagnostics Enzymes Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global In-vitro Diagnostics Enzymes Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global In-vitro Diagnostics Enzymes Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global In-vitro Diagnostics Enzymes Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global In-vitro Diagnostics Enzymes Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global In-vitro Diagnostics Enzymes Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global In-vitro Diagnostics Enzymes Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global In-vitro Diagnostics Enzymes Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global In-vitro Diagnostics Enzymes Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global In-vitro Diagnostics Enzymes Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global In-vitro Diagnostics Enzymes Sales Value by Region (2019-2024) & (%)
    Table 27. Global In-vitro Diagnostics Enzymes Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value, (2025-2030) & (US$ Million)
    Table 31. Merck KGaA Basic Information List
    Table 32. Merck KGaA Description and Business Overview
    Table 33. Merck KGaA In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 34. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Merck KGaA (2019-2024)
    Table 35. Merck KGaA Recent Developments
    Table 36. Codexis, Inc. Basic Information List
    Table 37. Codexis, Inc. Description and Business Overview
    Table 38. Codexis, Inc. In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 39. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Codexis, Inc. (2019-2024)
    Table 40. Codexis, Inc. Recent Developments
    Table 41. F. Hoffmann-La Roche Ltd. Basic Information List
    Table 42. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 43. F. Hoffmann-La Roche Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 44. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of F. Hoffmann-La Roche Ltd. (2019-2024)
    Table 45. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 46. Amano Enzyme Inc. Basic Information List
    Table 47. Amano Enzyme Inc. Description and Business Overview
    Table 48. Amano Enzyme Inc. In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 49. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Amano Enzyme Inc. (2019-2024)
    Table 50. Amano Enzyme Inc. Recent Developments
    Table 51. Advanced Enzymes Technologies Ltd. Basic Information List
    Table 52. Advanced Enzymes Technologies Ltd. Description and Business Overview
    Table 53. Advanced Enzymes Technologies Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 54. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Advanced Enzymes Technologies Ltd. (2019-2024)
    Table 55. Advanced Enzymes Technologies Ltd. Recent Developments
    Table 56. Biocatalysts Ltd. Basic Information List
    Table 57. Biocatalysts Ltd. Description and Business Overview
    Table 58. Biocatalysts Ltd. In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 59. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Biocatalysts Ltd. (2019-2024)
    Table 60. Biocatalysts Ltd. Recent Developments
    Table 61. Amicogen Basic Information List
    Table 62. Amicogen Description and Business Overview
    Table 63. Amicogen In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 64. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Amicogen (2019-2024)
    Table 65. Amicogen Recent Developments
    Table 66. Dyadic International Basic Information List
    Table 67. Dyadic International Description and Business Overview
    Table 68. Dyadic International In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 69. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Dyadic International (2019-2024)
    Table 70. Dyadic International Recent Developments
    Table 71. BBI Solutions Basic Information List
    Table 72. BBI Solutions Description and Business Overview
    Table 73. BBI Solutions In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 74. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of BBI Solutions (2019-2024)
    Table 75. BBI Solutions Recent Developments
    Table 76. Affymetrix Basic Information List
    Table 77. Affymetrix Description and Business Overview
    Table 78. Affymetrix In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 79. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of Affymetrix (2019-2024)
    Table 80. Affymetrix Recent Developments
    Table 81. American Laboratories Basic Information List
    Table 82. American Laboratories Description and Business Overview
    Table 83. American Laboratories In-vitro Diagnostics Enzymes Products, Services and Solutions
    Table 84. Revenue (US$ Million) in In-vitro Diagnostics Enzymes Business of American Laboratories (2019-2024)
    Table 85. American Laboratories Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. In-vitro Diagnostics Enzymes Downstream Customers
    Table 89. In-vitro Diagnostics Enzymes Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. In-vitro Diagnostics Enzymes Product Picture
    Figure 2. Global In-vitro Diagnostics Enzymes Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 4. In-vitro Diagnostics Enzymes Report Years Considered
    Figure 5. Global In-vitro Diagnostics Enzymes Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In-vitro Diagnostics Enzymes Revenue in 2023
    Figure 7. In-vitro Diagnostics Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Proteases Picture
    Figure 9. Polymerase & Transcriptase Picture
    Figure 10. Ribonuclease Picture
    Figure 11. Others Picture
    Figure 12. Global In-vitro Diagnostics Enzymes Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global In-vitro Diagnostics Enzymes Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Pharma & Biotech
    Figure 15. Product Picture of Hospital & Diagnostic Labs
    Figure 16. Product Picture of Contract Research Organizations (CROs)
    Figure 17. Product Picture of Academic Labs
    Figure 18. Global In-vitro Diagnostics Enzymes Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global In-vitro Diagnostics Enzymes Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa In-vitro Diagnostics Enzymes Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa In-vitro Diagnostics Enzymes Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions In-vitro Diagnostics Enzymes Sales Value (%), (2019-2030)
    Figure 31. United States In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 37. China In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 39. China In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 49. India In-vitro Diagnostics Enzymes Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India In-vitro Diagnostics Enzymes Sales Value by Type (%), 2023 VS 2030
    Figure 51. India In-vitro Diagnostics Enzymes Sales Value by Application (%), 2023 VS 2030
    Figure 52. In-vitro Diagnostics Enzymes Industrial Chain
    Figure 53. In-vitro Diagnostics Enzymes Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart